市場調查報告書
商品編碼
1354303
遠端病理學市場規模 - 按產品(掃描器、通訊系統、儲存系統)、按應用(遠端會診、藥物發現、疾病診斷)、按最終用途(醫院、學術和研究機構) - 到 2032 年的全球預測Telepathology Market Size - By Product (Scanner, Communication System, Storage System), By Application (Teleconsultation, Drug Discovery, Disease Diagnosis), By End-use (Hospitals, Academic & Research Institutes) - Global Forecast to 2032 |
2023 年至 2032 年,全球遠距病理市場規模將以 12.4% 的複合年成長率成長。
VR(虛擬實境)和 AR(擴增實境)應用程式的持續實驗和開發,旨在增強數位病理影像的可視化和交互,為病理學家提供更身臨其境的體驗,這將促進市場成長。 AR 和 VR 技術在增強病理學家能力方面的發展提高了診斷準確性,最終有利於病患照護。
整個遠距病理學市場根據產品、應用、最終用途和地區分為兩部分。
從產品來看,2023-2032年通訊系統產業價值複合年成長率將達12.8%。遠距病理通訊系統和技術使病理學家和醫療專業人員能夠遠端協作、分享專業知識並提供及時的診斷和諮詢。一些醫療機構和公司還提供專門的遠距病理諮詢平台,用於整合各種通訊和診斷工具,以簡化遠距病理流程。即時視訊會議工具的湧入使病理學家和專家能夠分享見解和討論病例,也將有利於該細分市場的成長。
就應用而言,到 2032 年,藥物發現領域的遠端病理學市場規模預計將成長 12.3%。這一成長可歸因於遠端病理學在簡化和加速藥物發現流程、同時促進高效資料共享方面的重要性日益提高。協作以及遠端專業知識利用。重大技術進步將進一步推動遠距病理學在藥物研發工作中的採用。
從地區來看,由於人們日益關注加強偏遠地區的醫療保健服務,預計到 2032 年,亞太地區遠距病理學產業的複合年成長率將超過 13%。該地區的一些政府正在提出遠距病理學計劃,以改善獲得病理服務的機會。舉個例子,2022年1月,印度發起「Heal in India」計劃,以促進醫療旅遊業的成長。不斷發展的遠距病理服務監管框架也將促進區域市場的成長。
Global telepathology market size will expand at 12.4% CAGR from 2023-2032.
The rising experimentation and development of VR (virtual reality) and AR (augmented reality) applications for enhancing the visualization and interaction with digital pathology images to render more immersive experience for pathologists will add to the market growth. The evolution of AR and VR technologies in enhancing the capabilities of pathologists has led to enhanced diagnostic accuracy, ultimately benefiting patient care.
The overall telepathology market is bifurcated based on product, application, end-use and region.
Based on product, the industry value from communication system will register 12.8% CAGR from 2023-2032. Telepathology communication systems and technologies enable pathologists and medical professionals to remotely collaborate, share expertise, and offer timely diagnoses and consultations. Several healthcare institutions and companies are also offering specialized telepathology consultation platforms for integrating various communication and diagnostic tools to streamline the telepathology process. The influx of real-time video conferencing tools to enable pathologists and specialists to share insights and discuss cases will also prove favorable for the segment growth.
With respect to application, the telepathology market size from the drug discovery segment is slated to observe 12.3% rate up to 2032. The growth can be attributed to the rising importance of telepathology in streamlining and accelerating the drug discovery processes while facilitating efficient data sharing, collaboration as well as remote expertise utilization. The significant technology advances will further drive the adoption of telepathology in pharmaceutical R&D efforts.
Regionally, the Asia Pacific telepathology industry is expected to witness over 13% CAGR through 2032 due to the surging focus on enhancing healthcare access in remote areas. Several governments in the region are coming up with telepathology initiatives for improving access to pathology services. To cite an instance, in January 2022, the 'Heal in India' initiative was launched in India to boost the medical tourism growth. The evolving regulatory frameworks for telepathology services will also add to the regional market growth.